Overview
Angel investor focused on science, engineering, and software startups.
Founded
2011
Deals · 12mo
2
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Singular Photonics | Aug 2026Participated | $2 MOther Equity | |
HotHouse Therapeutics | Dec 2025Participated | $4 MSeed | |
Monument Therapeutics | Feb 2025Participated | $1 MOther Equity | |
MitoRx Therapeutics | Dec 2023Participated | $5 MSeed | |
Spotta | Dec 2023Participated | $4 MOther Equity | |
PharmEnable | May 2023Participated | $8 MSeries A | |
Centauri Therapeutics | Feb 2022Participated | $33 MSeries A | |
Tay Therapeutics | Nov 2021Participated | $2 MSeries A | |
Monument Therapeutics | Jul 2021Participated | $4 MSeed | |
Adapttech | Mar 2021Participated | $3 MOther Equity | |
Spotta | Jul 2020Participated | $1 MSeed | |
PharmEnable | Jun 2020Participated | $2 MSeed | |
Singular Photonics | Aug 2026Participated | $2 MOther Equity | |
HotHouse Therapeutics | Dec 2025Participated | $4 MSeed | |
Monument Therapeutics | Feb 2025Participated | $1 MOther Equity | |
MitoRx Therapeutics | Dec 2023Participated | $5 MSeed | |
Spotta | Dec 2023Participated | $4 MOther Equity | |
PharmEnable | May 2023Participated | $8 MSeries A | |
Centauri Therapeutics | Feb 2022Participated | $33 MSeries A | |
Tay Therapeutics | Nov 2021Participated | $2 MSeries A | |
Monument Therapeutics | Jul 2021Participated | $4 MSeed | |
Adapttech | Mar 2021Participated | $3 MOther Equity | |
Spotta | Jul 2020Participated | $1 MSeed | |
PharmEnable | Jun 2020Participated | $2 MSeed |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 5 |
| Series A | 0 | 4 |
| Other Equity | 0 | 9 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jun '12 | 1 |
| Jul '12 | 0 |
| Aug '12 | 0 |
| Sep '12 | 0 |
| Oct '12 | 0 |
| Nov '12 | 0 |
| Dec '12 | 0 |
| Jan '13 | 0 |
| Feb '13 | 0 |
| Mar '13 | 0 |
| Apr '13 | 0 |
| May '13 | 0 |
| Jun '13 | 0 |
| Jul '13 | 0 |
| Aug '13 | 1 |
| Sep '13 | 0 |
| Oct '13 | 0 |
| Nov '13 | 0 |
| Dec '13 | 0 |
| Jan '14 | 0 |
| Feb '14 | 0 |
| Mar '14 | 0 |
| Apr '14 | 1 |
| May '14 | 0 |
| Jun '14 | 1 |
| Jul '14 | 0 |
| Aug '14 | 0 |
| Sep '14 | 0 |
| Oct '14 | 0 |
| Nov '14 | 0 |
| Dec '14 | 0 |
| Jan '15 | 0 |
| Feb '15 | 1 |
| Mar '15 | 0 |
| Apr '15 | 0 |
| May '15 | 0 |
| Jun '15 | 0 |
| Jul '15 | 0 |
| Aug '15 | 0 |
| Sep '15 | 0 |
| Oct '15 | 0 |
| Nov '15 | 0 |
| Dec '15 | 0 |
| Jan '16 | 0 |
| Feb '16 | 0 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 0 |
| Aug '16 | 0 |
| Sep '16 | 1 |
| Oct '16 | 0 |
| Nov '16 | 0 |
| Dec '16 | 0 |
| Jan '17 | 0 |
| Feb '17 | 0 |
| Mar '17 | 0 |
| Apr '17 | 0 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 0 |
| Sep '17 | 0 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 1 |
| Jul '20 | 1 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 1 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 1 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 2 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 1 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 12 |
| Hardware & Robotics | 5 |
| Space & Frontier Tech | 3 |
| Travel & Hospitality | 2 |
| Manufacturing | 2 |
| Professional Services | 2 |
| Consumer & Lifestyle | 2 |
| Food & Agriculture | 1 |
| Clean Energy & Sustainability | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 15 |
| $5M-$10M | 2 |
| $10M-$25M | 0 |
| $25M-$50M | 1 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 18 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| ACF Investors | 7 |
| o2h Ventures | 5 |
| Cambridge Angels | 4 |
| Martlet Capital | 4 |
| Cambridge Enterprise | 3 |
| Cambridge Capital Group | 2 |
| Catapult Ventures | 2 |
| London Business Angels | 2 |
| Qi3 Accelerator | 2 |
| Remus Capital | 2 |
| Scottish Enterprise | 2 |
| University of Cambridge | 2 |
| 24Haymarket | 1 |
| Animatrix Capital | 1 |
| Arrowfield Capital | 1 |
| Bionova Capital | 1 |
| Boehringer Ingelheim | 1 |
| Catamaran Ventures | 1 |
| East Midlands Business Angels | 1 |
| Evotec | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 18 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range
Team
Managing Partner
